Overview
Whether you're seeking support for metabolic health, hormonal balance, or longevity optimization, Jardiance® (empagliflozin) may be part of your personalized care plan at Meto.
Insurance coverage for Jardiance® (empagliflozin) can vary based on your plan type, your medical diagnosis, and the intended use. Here's what you need to know about using Centene (Ambetter, WellCare) for Jardiance® (empagliflozin).
Coverage Overview: Jardiance® (empagliflozin) and Centene (Ambetter, WellCare)
What you should expect:
Coverage for Diagnosed Conditions:
Jardiance® (empagliflozin) may be covered if prescribed for certain diagnoses (e.g., Type 2 Diabetes, hypogonadism, thyroid disease). Coverage for preventive or longevity use is less common.
Prior Authorization Requirements:
In most cases, approval requires demonstrating medical necessity through labs, clinical history, and prior treatments.
Copays and Costs:
If approved, you may pay a specialist-tier copay or percentage coinsurance based on your Centene (Ambetter, WellCare) plan.
Alternative Options if Not Covered:
Meto supports patients by offering cash-pay pricing and exploring medication discounts if insurance does not cover Jardiance® (empagliflozin).
If Centene (Ambetter, WellCare) Doesn’t Fully Cover Jardiance® (empagliflozin)
If your plan does not cover Jardiance® (empagliflozin), Meto offers competitive self-pay options and flexible financing to ensure you still have access to needed care.
We’re committed to making metabolic and longevity care accessible to you.
